JAMP-INDAPAMIDE
JAMP PHARMA CORPORATION
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is JAMP-INDAPAMIDE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that JAMP-INDAPAMIDE 1.25MG has been permanently discontinued (last updated February 18, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
APO-INDAPAMIDE 1.25 MG TABLETS
APOTEX INC
Other Products
MYLAN-INDAPAMIDE
MYLAN PHARMACEUTICALS ULC
APO-INDAPAMIDE 2.5MG TABLETS
APOTEX INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02373904
Strength
1.25MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
250MG · DIN 02529459
50MG · DIN 02423227
5MG · DIN 02429217
2.5MG · DIN 02492199
10MG · DIN 02429225
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164